EN FR
Homepage Inria website


Section: Partnerships and Cooperations

European Initiatives

FP7 & H2020 Projects

VPH-Share
  • Type: FP7

  • Defi: Towards sustainable and personalised healthcare

  • Instrument: Integrated Project

  • Objectif: Virtual Physiological Human

  • Duration: March 2011 - February 2015

  • Coordinator: Univ. Sheffield (UK)

  • Other partners: Cyfronet (Cracow), University College London, Istituto Ortopedico Rizzoli (Bologna), NHS, IBM Israel, Univ. Auckland, Agència d'Informació, Avaluació i Qualitat en Salut (Barcelona), Biocomputing Competence Centre (Milano), Universitat Pompeu Fabra (Barcelona), Philips Research, TUE (Eindhoven), Sheffield Teaching Hospitals, Atos Origin (Madrid), the Open University (UK), Univ. Vienna, King's College London, Empirica (Bonn), Fundació Clínic (Barcelona), Univ. Amsterdam

  • See also: http://vph-share.org/

  • Abstract: VPH-Share aims at developing the organisational fabric (the infostructure) and integrating the optimised services to expose and share data and knowledge, to jointly develop multiscale models for the composition of new VPH workflows, and to facilitate collaborations within the VPH community. Within this project, the M3DISIM team is in charge of developing some high-performance data assimilation software tools.

VP2HF
  • Type: FP7

  • Defi: ICT for Health, Ageing Well, Inclusion and Governance

  • Instrument: Specific Targeted Research Project

  • Objectif: Virtual Physiological Human

  • Duration: October 2013 - September 2016

  • Coordinator: King's College London (UK)

  • See also: http://vp2hf.eu/

  • Abstract: Heart failure (HF) is one of the major health issues in Europe affecting 6 million patients and growing substantially because of the aging population and improving survival following myocardial infarction. The poor short to medium term prognosis of these patients means that treatments such as cardiac re-synchronisation therapy and mitral valve repair can have substantial impact. However, these therapies are ineffective in up to 50% of the treated patients and involve significant morbidity and substantial cost. The primary aim of VP2HF is to bring together image and data processing tools with statistical and integrated biophysical models mainly developed in previous VPH projects, into a single clinical workflow to improve therapy selection and treatment optimisation in HF.